Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16582060

Download in:

View as

General Info

PMID
16582060